Notice To Announce Supplemental Awards To Support Training and Technical Assistance To Address Intimate Partner Violence, 61758 [2020-21573]

Download as PDF 61758 Federal Register / Vol. 85, No. 190 / Wednesday, September 30, 2020 / Notices captioning will be provided. Please check the meeting website for the latest information: https://www.fda.gov/drugs/ news-events-human-drugs/publicmeeting-patient-focused-drugdevelopment-stimulant-use-disorder03102020-03102020. Streaming Webcast of the Public Meeting: This public meeting will be streamed via webcast only. The recording and presentation slides, along with a meeting transcript and summary report, will also be made publicly available after the meeting. To register for the webcast, please visit https:// pfdd-stimulantuse disorder.eventbrite.com. The webcast can be accessed via http:// fda.yorkcast.com/webcast/Play/ 89f7acb8d56e4de8827d 1ade8efa42661d. Simply click on the link and hit the ‘‘play’’ button and it will start. The webcast link will be activated 30 minutes prior to the start of the meeting. FDA has verified the website addresses in this document, as of the date this document publishes in the Federal Register, but websites are subject to change over time. Transcripts: Please be advised that as soon as a transcript of the public meeting is available, it will be accessible at https://www.regulations.gov. It may be viewed at the Dockets Management Staff (see ADDRESSES). A link to the transcript will also be available on the meeting website at https://www.fda.gov/ drugs/news-events-human-drugs/publicmeeting-patient-focused-drugdevelopment-stimulant-use-disorder03102020-03102020. Dated: September 24, 2020. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2020–21623 Filed 9–29–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration BILLING CODE 4165–16–P Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice of Supplemental Awards. jbell on DSKJLSW7X2PROD with NOTICES HRSA provided supplemental funding to two current National Training and Technical Assistance Partners award recipients to advance 17:36 Sep 29, 2020 Jkt 250001 Justification: Supplemental funding to SBHA and Futures is necessary to ensure timely implementation of expanded T/TA that builds upon current T/TA activities to strengthen health center capacity to identify, prevent, and address intimate partner violence (IPV) and its effects. SBHA’s expanded T/TA will result in new and strengthened health center partnerships to protect and support children, increased health center capacity to address social determinants of health, and expanded health center strategies to prevent violence. Futures’ expanded T/ TA will expand health center use of electronic health records to support IPV and human trafficking interventions, increase collection of health center IPV and human trafficking data, and strengthen the use of health information technology to connect health center patients to referral services and support. The award recipients have the demonstrated subject matter expertise and experience required to swiftly address these time-sensitive needs. [FR Doc. 2020–21573 Filed 9–29–20; 8:45 am] AGENCY: VerDate Sep<11>2014 Authority: Section 330(l) of the Public Health Service Act, 42 U.S.C. 254b(l). Thomas J. Engels, Administrator. Notice To Announce Supplemental Awards To Support Training and Technical Assistance To Address Intimate Partner Violence SUMMARY: HRSA’s Strategy to Address Intimate Partner Violence by expanding critical training and technical assistance (T/TA) to health centers. FOR FURTHER INFORMATION CONTACT: Tracey Orloff, Director, HRSA, Strategic Partnerships Division, Office of Quality Improvement, at TOrloff@hrsa.gov or (301) 443–3197. SUPPLEMENTARY INFORMATION: Recipients of the Award: SchoolBased Health Alliance (SBHA) and Futures without Violence (Futures). Amount of Non-Competitive Award: $75,000 for SBHA and $100,000 for Futures. Period of Supplemental Funding: Fiscal year 2020 and ongoing annually to the end of the project period, contingent upon availability of funds and recipient performance. CFDA Number: 93.129. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Biobehavioral and Behavioral Processes Integrated Review Group; Biobehavioral Mechanisms of Emotion, Stress and Health Study Section. Date: October 28–30, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sara Louise Hargrave, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301) 443–7193, hargravesl@mail.nih.gov. Name of Committee: Emerging Technologies and Training Neurosciences Integrated Review Group; Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section. Date: October 29–30, 2020. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Robert C. Elliott, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5190, MSC 7846, Bethesda, MD 20892, 301–435– 3009, elliotro@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Clinical Neuroscience and Neurodegeneration Study Section. Date: October 29–30, 2020. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Alessandra C. Rovescalli, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Rm 5205, MSC7846, Bethesda, MD 20892, (301) 435– 1021, rovescaa@mail.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Acute Neural Injury and Epilepsy Study Section. Date: October 29–30, 2020. Time: 8:30 a.m. to 6:00 p.m. E:\FR\FM\30SEN1.SGM 30SEN1

Agencies

[Federal Register Volume 85, Number 190 (Wednesday, September 30, 2020)]
[Notices]
[Page 61758]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21573]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Notice To Announce Supplemental Awards To Support Training and 
Technical Assistance To Address Intimate Partner Violence

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice of Supplemental Awards.

-----------------------------------------------------------------------

SUMMARY: HRSA provided supplemental funding to two current National 
Training and Technical Assistance Partners award recipients to advance 
HRSA's Strategy to Address Intimate Partner Violence by expanding 
critical training and technical assistance (T/TA) to health centers.

FOR FURTHER INFORMATION CONTACT: Tracey Orloff, Director, HRSA, 
Strategic Partnerships Division, Office of Quality Improvement, at 
[email protected] or (301) 443-3197.

SUPPLEMENTARY INFORMATION: 
    Recipients of the Award: School-Based Health Alliance (SBHA) and 
Futures without Violence (Futures).
    Amount of Non-Competitive Award: $75,000 for SBHA and $100,000 for 
Futures.
    Period of Supplemental Funding: Fiscal year 2020 and ongoing 
annually to the end of the project period, contingent upon availability 
of funds and recipient performance.
    CFDA Number: 93.129.

    Authority: Section 330(l) of the Public Health Service Act, 42 
U.S.C. 254b(l).

    Justification: Supplemental funding to SBHA and Futures is 
necessary to ensure timely implementation of expanded T/TA that builds 
upon current T/TA activities to strengthen health center capacity to 
identify, prevent, and address intimate partner violence (IPV) and its 
effects. SBHA's expanded T/TA will result in new and strengthened 
health center partnerships to protect and support children, increased 
health center capacity to address social determinants of health, and 
expanded health center strategies to prevent violence. Futures' 
expanded T/TA will expand health center use of electronic health 
records to support IPV and human trafficking interventions, increase 
collection of health center IPV and human trafficking data, and 
strengthen the use of health information technology to connect health 
center patients to referral services and support. The award recipients 
have the demonstrated subject matter expertise and experience required 
to swiftly address these time-sensitive needs.

Thomas J. Engels,
Administrator.
[FR Doc. 2020-21573 Filed 9-29-20; 8:45 am]
BILLING CODE 4165-16-P